Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed-Reference-Cited by-同舟云学术

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

Published:2020-12 Issue:4 Volume:13 Page:363-364
ISSN:1865-5041
Container-title:memo - Magazine of European Medical Oncology
language:en
Short-container-title:memo

Author:

Königsrainer Ingmar

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12254-020-00655-4.pdf

Reference5 articles.

1. Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018; https://doi.org/10.1200/JCO.2018.36.18_SUPPL.LBA3503.

2. Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré Ch, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258(1):116–21.

3. Horvarth P, Königsrainer I. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer. memo. 2020;13(4). https://doi.org/10.1007/s12254-020-00633-w.

4. Gasser E, Kogler P, Lorenz A, Kafka-Ritsch R, Öfner D, Perathoner A. Do we still need CRS and HIPEC in colorectal cancer in times of modern chemotherapy and immunotherapy? memo. 2020;13(4) https://doi.org/10.1007/s12254-020-00647-4.

5. Yurttas C, Fisher OM, Cortés-Guiral D, Haen SP, Königsrainer IA, Beckert S, Liauw W,·Löffer MW. Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick? memo 2020;13(4).https://doi.org/10.1007/s12254-020-00653-6.